We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

  • This share is currently suspended. It was suspended at a price of 0.10

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.10
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.10
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

23 Feb 2022 07:00

RNS Number : 5401C
CAP-XX Limited
23 February 2022
 

 

Dissemination of a Regulatory Announcement that contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

 

 

23 February 2022

 

 

CAP-XX Limited

("CAP-XX" or the "Company")

 

Interim Results for the half-year ended 31 December 2021

 

 

CAP-XX Limited, a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems, is pleased to announce its interim results for the half-year ended 31 December 2021.

 

Key highlights

 

· Total revenue up 14% on corresponding half-year

· Product sales up 40% driven by DMF/DMT product lines and IoT markets

· Sales order book at 31/12/21 more than 40% higher than 31/12/20

· Sales pipeline now in excess of US$50 million p.a. Interest from global multinational companies increasing, especially for DMH, DMF and DMT products

· Performance and output of Seven Hills production increased significantly. GM% greater than 50%

· No royalty or licence income recognised in period

· CAP-XX is vigorously pursuing Maxwell for patent infringement and AVX for breach of patent licence agreement

· Adjusted EBITDA was a loss of A$0.3 million (2020: Adjusted EBITDA profit A$0.3 million)

· Cash reserves as at 31 December 2021 were A$5.1 million

 

* Adjusted EBITDA excludes net Murata project costs, patent infringement costs and AASB16 expenses

 

Anthony Kongats, CEO of CAP-XX said:

"We are delighted with the increase in product sales and the pipeline of new sales opportunities matched by improvements in our manufacturing operations most notably at Seven Hills, NSW, Australia. We look forward to the second half of the year."

Electronic copies of CAP-XX's interim results for the half-year ended 31 December 2021 will shortly be available from the Company's website: www.cap-xx.com.

 

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Alex Brearley (Corporate Finance) +44 (0) 20 3328 5656

Tony Quirke (Sales and Corporate Broking)

 

Cenkos Securities plc (Joint Broker)

Neil McDonald / Pete Lynch +44 (0) 13 1220 6939

 

 

 

More information is available at www.cap-xx.com

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

Chairman's statement

The first half of the current financial year has been characterised by continued strong sales demand. Product sales at A$2.4 million are up 40% on the corresponding period last year (A$1.7 million) and the order book at the end of December 2021 was more than 40% higher than at the same time last year. Pleasingly, the growth in the order book continues to be well spread, coming from all geographic regions and from different Internet of things ("IoT") related market segments.

 

During this period, there were no royalty payments recognised from Kyocera AVX Components Corporation (formerly AVX Corporation) ("AVX") and Murata. Total revenue was up 14% at A$2.4 million compared to A$2.1 million. The reported Net Loss for the period was A$(1.7 million). This compared to a Net Loss of A$(1.2 million) for the corresponding period last year.

 

The adjusted EBITDA result for the six months ended December 2021, which excludes the impact from the Murata project expenditure and patent infringement legal expenses, was a loss of A$0.3 million (2020: Profit A$0.3 million). The principal reasons for the year-on-year variance was the absence of both royalty and licensing revenue in 2021 (2020: A$0.4 million), no government assistance payments associated with COVID in the half year (2020: A$0.3 million) and the A$0.3 million increase in operational expenses at Seven Hills as part of the ramp up of production at Seven Hills.

 

Sales for automotive accessories, electronic locks and battery-less energy harvesting products have been particularly strong. Around 30 customers moved into production from the design win stage, and several other customers have designed CAP-XX products into a second or third product, broadening our sales base. At the same time, the Company achieved several new design wins in industrial, wearables, consumer, medical, and automotive products.

 

Of particular importance, the Company is seeing increasing interest in its products from global multinational companies. The Company has notably achieved a design win with Continental, a global Tier-1 automotive component supplier, and has signed a supply agreement for models to be produced in 2024 - 2030.

 

The Board believes that demand for both non-cellular and cellular IoT devices will continue to grow rapidly. This is reflected by the Company's sales pipeline now growing to in excess of US$50 million per annum. This pipeline has been growing rapidly and the rate of design wins has been accelerating.

 

As previously reported, the global pandemic has continued to impact parts of the Company's operations, most noticeably in our various manufacturing activities at Seven Hills as well as in Asia. Disrupted supply chains, shortages of technicians and operators, global travel restrictions, limited international flights and mandatory quarantine requirements have presented headwinds. Nevertheless, as a whole, the Company has made excellent operational progress.

 

Production at Seven Hills continues to improve to plan. Gross margins for products made at Seven Hills now exceed 50% (FY 2021: 37%) and are expected to increase further. The current output and key performance metrics are tracking in line with our expectations. As expected at this stage of production, the Company is continuing to address small incremental improvements and is hiring additional staff for the Seven Hills facility. We expect to see steady improvement over the remainder of 2022. The Board is confident that target outputs and other key performance metrics will be reached as expected. The commissioning of the fourth production line, the DMH line, is expected to be completed within 12 months, with production expected to start in the first quarter of 2023 as time and resources allow and subject to customer demand.

 

CAP-XX's Asian operations have also been impacted by the pandemic. Various government mandated lockdowns have restricted the Company's ability to increase output as fast as management would have liked in response to the growing sales order book. Most noticeably, we have faced delays in recruiting additional staff and have been unable to travel from Seven Hills to Asia to oversee pre-production manufacturing of new products and processes. Nevertheless, CAP-XX has successfully increased output and expects normal travel to resume shortly.

 

The Australian Government recently released the Government's first List of Critical Technologies in the National Interest. The Government lists supercapacitors as a critical technology of national interest. CAP-XX is the only manufacturer in Australia of supercapacitors and the only Australian company manufacturing supercapacitors. The Company has won projects with Australian government agencies for the supply of supercapacitors for the development of critical technologies. During the half year one of these projects was successfully completed and delivered to the Government.

 

These and other R&D activities continue to progress and promising developments in new intellectual property were established to reduce supercapacitor production costs, increase cell voltage and improve product performance, using new materials. The Company is in discussions with other companies regarding licencing and partnering opportunities. The Company expects several new products to eventually be launched on the back of these combined efforts, including an even thinner and cheaper supercapacitor and large supercapacitor modules.

 

Although no royalty or licence income was recorded in the period, licensing remains an important potential revenue stream for CAP-XX and the Company continues to defend its intellectual property. CAP-XX continues to vigorously pursue its patent infringement action against Maxwell Technologies, now a wholly owned subsidiary of Tesla Inc. and other companies. The same Delaware court which ruled in favour of CAP-XX against Ioxus is also hearing the case against Maxwell Technologies and has issued a timetable for resolution of this matter. Efforts at mediation have so far been unsuccessful and the Company is preparing for a trial date starting in October 2022. The Board remains optimistic of the Company's prospects in this matter. We are currently in a dispute with Kyocera AVX Components Corporation (formerly AVX Corporation) (AVX) in respect of allegations that AVX breached our patent licence agreement, including by failing to pay all royalties payable to CAP-XX. The matter is currently before the Supreme Court of New South Wales. A further announcement will be made at the appropriate time and the Company's expectation is that this will be resolved in the current financial year.

The Board is confident that the growth of sales for IoT devices and the new Seven Hills production lines will transform the Company's revenue position with a consequential benefit to cash flow and the cash position of the Company. We expect to be EBITDA positive in the next financial year and turn cashflow positive during the second half of the same financial year. Further, as the sales pipeline is currently in excess of US$50 million, there is also the possibility of bringing these milestones forward should we secure large orders.

 

 

 

Patrick Elliott

Chairman

 

 

 

 

 

 

CAP-XX Limited

Consolidated statement of profit or loss

For the half-year ended 31 December 2021

 

 

Consolidated

 

 

 

Half-year 2021

Half-year 2020

 

 

 

 

Currency: Australian Dollars

 

$

$

 

 

 

 

Revenue from sale of goods and services

 

2,428,416

2,126,564

Cost of sale of goods and services

 

(1,604,829)

(1,158,340)

Gross margin (loss) on sale of goods and services

 

823,587

968,224

 

 

 

 

Other revenue

 

3,120

501

Other income

 

 

1,169,442

 

2,292,781

 

 

 

 

General and administrative expenses

 

(1,484,788)

(944,949)

Process and engineering expenses

 

(490,505)

(229,994)

Selling and marketing expenses

 

(392,564)

(437,791)

Research and Development expenses

 

(729,501)

(740,021)

Project expenses

 

-

(2,017,614)

Share based payments

 

(435,053)

(68,192)

Other expenses

 

(200,186)

(67,250)

(Loss) before income tax

 

(1,736,448)

(1,244,305)

 

 

 

 

Income tax benefit/(expense)

 

-

-

Net loss after income tax for the half year

 

(1,736,448)

(1,244,305)

 

 

 

 

(Loss) attributable to members of CAP-XX Limited

 

(1,736,448)

(1,244,305)

 

 

 

 

Loss per share attributable to the ordinary equity holders of the company

 

Cents

Cents

Basic loss per share

 

(0.35)

(0.28)

Diluted loss per share

 

(0.35)

(0.28)

 

 

 

 

     

 

 

 

CAP-XX Limited

Consolidated statement of comprehensive income

For the half year ended 31 December 2021

 

 

 

Consolidated

 

 

 

 

 

 

 

 

2021

2020

 

Currency: Australian Dollars

 

$

$

 

Loss for the half year

 

(1.736,448)

(1,244,305)

 

Other comprehensive income

 

 

 

 

Items that may be reclassified subsequently to profit or loss

 

 

 

 

 

 

Exchange differences on translation of foreign operations

 

(33,476)

102,943

 

Other comprehensive loss for the half year, net of tax

 

(33,476)

102,943

 

Total comprehensive loss for the half year attributable to owners of CAP-XX Limited

 

(1,769,924)

(1,141,362)

 

 

 

 

 

 

 

 

 

CAP-XX Limited

Consolidated statement of financial position

As at 31 December 2021

 

 

 

Consolidated

 

 

 

31 December 2021

31 December 2020

 

 

 

 

 

 

 

Currency: Australian Dollars

 

 

$

$

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

 

5,055,747

469,472

 

Receivables

 

 

1,123,331

455,454

 

Inventories

 

 

1,076,799

1,041,169

 

Other

 

 

1,203,308

5,698,264

 

Total current assets

 

 

8,459,185

7,664,359

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

Property, plant and equipment

 

 

2,872,517

2,624,744

 

Right of Use Assets

 

 

2,727,890

3,059,608

 

Other

 

 

397,063

204,808

 

Total non-current assets

 

 

5,997,470

5,889,160

 

 

 

 

 

 

 

TOTAL ASSETS

 

 

14,456,655

13,553,519

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

Current liabilities

 

 

 

 

 

Payables

 

 

1,050,141

1,489,078

 

Lease Liabilities

 

 

134,546

268,051

 

Advance payments - Current

 

 

-

1,442,900

 

Provisions

 

 

795,164

1,401,354

 

Total current liabilities

 

 

1,979,851

4,601,383

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

Lease Liabilities

 

 

2,348,248

2,241,620

 

Provisions

 

 

761,529

53,332

 

Total non-current liabilities

 

 

3,109,777

2,294,952

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

5,089,628

6,896,335

 

 

 

 

 

 

 

NET ASSETS

 

 

9,367,027

6,657,184

 

 

 

 

 

 

 

 

 

 

 

 

 

EQUITY

 

 

 

 

 

Contributed equity

 

 

114,511,789

108,153,306

 

Reserves

 

 

6,835,441

6,461,120

 

Accumulated losses

 

 

(111,980,203)

(107,957,242)

 

TOTAL EQUITY

 

 

9,367,027

6,657,184

 

 

 

 

 

 

 

 

 

 

 

 

CAP-XX Limited

Consolidated statements of changes in equity

For the half-year ended 31 December 2021

 

Consolidated

 

 

 

 

Contributed

Equity

$

Reserve

$

Accumulated losses

$

Total

$

 

 

 

 

 

 

Balance at 1 July 2020

 

108,010,106

6,289,985

(106,712,937)

7,587,154

Loss for the period as reported in the 2020 financial statements

 

(3,530,818)

(3,530,818)

 

Other comprehensive loss

 

- 

38,766

-

 

38,766

Transactions with owners in their capacity as owners:

 

 

 

 

 

Contributions of equity, net of transaction costs and tax

 

756,424

 

 

756,424

Employee share options ‑ value of employee services

 

 

-

105,113

-

105,113

 

 

 

 

 

 

Balance at 30 June 2021

 

108,766,530

6,433,864

(110,243,755)

 4,956,639

 

Profit for the period as reported in the 2021 interim financial statements

 

- 

-

(1,736,448)

(1,736,448)

Other comprehensive income

 

- 

(33,476)

-

 

(33,476)

Transactions with owners in their capacity as owners:

 

 

 

 

 

Contributions of equity, net of transaction costs and tax

 

5,745,259

 -

 -

5,745,259

Employee share options ‑ value of employee services

 

-

435,053

-

435,053

 

 

 

 

 

 

Balance at 31 December 2021

 

114,511,789

6,835,441

 (111,980,203)

9,367,027

 

 

 

 

 

 

 

 

 

 

 

 

CAP-XX Limited

Consolidated Statement of Cash Flows

For the half-year ended 31 December 2021

 

 

Consolidated

 

 

Half-year 2021

Half-year 2020

 

 

 

 

Currency: Australian Dollars

 

$

$

 

 

 

 

Cash flows from operating activities

 

 

 

Receipts from customers (inclusive of goods and services tax)

 

2,565,957

2,460,431

Payments to suppliers and employees (inclusive of goods and services tax)

 

(5,191,497)

(5,397,193)

 

 

(2,625,540)

(2,936,762)

Tax credit received

 

3,211,314

-

Interest received

 

3,121

501

Net cash (outflow) from operating activities

 

588,895

(2,936,261)

 

 

 

 

Cash flows from investing activities

 

 

 

Payments for property, plant and equipment

 

(27,532)

(1,178,792)

Net cash (outflow) from investing activities

 

(27,532)

(1,178,792)

 

 

 

 

Cash flows from financing activities

 

 

 

Proceeds from issue of shares

 

5,745,259

143,200

Advance payments

 

(1,400,000)

1,442,900

Net cash inflow from financing activities

 

4,345,259

1,586,100

 

 

 

 

Net (decrease) in cash and cash equivalents

 

4,906,622

(2,528,953)

Cash and cash equivalents at the beginning of the half-year

 

182,601

2,895,482

Effects of exchange rate changes on cash and cash equivalents

 

(33,476)

102,943

Cash and cash equivalents at the end of the half-year

 

 

5,055,747

469,472

 

 

 

 

 

 

 

 

This general purpose interim financial report, for the half-year reporting period ended 31 December 2021, has been prepared in accordance with Australian equivalents to International Financial Reporting Standards (AIFRSs), other authoritative pronouncements of the Australian Accounting Standards Board, Urgent Issues Group Interpretations and the Corporations Act 2001. This general purpose interim financial report, for the half-year reporting period ended 31 December 2021, is unaudited.

 

 

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR EAKADAELAEEA
Date   Source Headline
8th Apr 20249:12 amRNSLitigation with Kyocera AVX settled
28th Mar 20245:00 pmRNSTotal Voting Rights
27th Mar 20248:22 amRNSSuspension of trading
27th Mar 20247:29 amRNSN04/24 - CAP-XX Limited - Suspension of trading
25th Mar 20247:00 amRNSResult of Retail Offer and Total Voting Rights
22nd Mar 20247:00 amRNSResult of Placing and Notice of General Meeting
21st Mar 20244:40 pmRNSREX Retail Offer
21st Mar 20244:35 pmRNSProposed Placing and Subscription to raise £2.0m
21st Mar 20249:00 amRNSLitigation Settlement Agreement with Tesla, Inc
19th Mar 202412:31 pmRNSHolding(s) in Company
18th Mar 20242:56 pmRNSHolding(s) in Company
15th Mar 202412:50 pmRNSHolding(s) in Company
15th Mar 20247:07 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSUpdate on litigation
13th Mar 20247:00 amRNSCorporate Update
12th Mar 20247:00 amRNSRetirement of CFO
28th Feb 20247:00 amRNSUpdate on litigation and trading
19th Feb 20247:00 amRNSCessation of appeals process
1st Feb 20247:00 amRNSInterim Results
29th Jan 20247:00 amRNSUpdate on Patent Infringement
22nd Jan 202412:57 pmRNSChange of Joint Broker
10th Jan 20247:02 amRNSUpdate on IP and appeals process
29th Dec 20231:00 pmRNSTotal Voting Rights
21st Dec 20237:00 amRNSTrading Update
18th Dec 20237:00 amRNSUpdate on Patent Infringement
7th Dec 20237:00 amRNSCAP-XX finalises two new patents
5th Dec 20237:00 amRNSIssue of Shares and Director/PDMR Shareholdings
1st Dec 20237:00 amRNSUpdate re. R&D rebate and other matters
29th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 202311:29 amRNSHolding(s) in Company
3rd Nov 20239:05 amRNSResult of AGM and Directorate Change
3rd Nov 20237:05 amRNSAGM Trading Update
26th Oct 20232:05 pmRNSHolding(s) in Company
13th Oct 20239:45 amRNSNotice of AGM
4th Oct 20237:00 amRNSExpansion of sales operations
29th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
14th Sep 202312:29 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSPre-close Trading Update and Notice of Results
31st Jul 20239:53 amRNSHolding(s) in Company
18th Jul 202310:27 amRNSUpdate on Patent Infringement
30th Jun 20235:00 pmRNSTotal Voting Rights
13th Jun 20237:00 amRNSHolding(s) in Company
9th Jun 20237:53 amRNSAppointment of Chief Executive Officer
8th Jun 20238:38 amRNSHolding(s) in Company
8th Jun 20237:00 amRNSHolding(s) in Company
6th Jun 202311:38 amRNSHolding(s) in Company
2nd Jun 20238:36 amRNSResult of General Meeting
31st May 20235:00 pmRNSTotal Voting Rights
19th May 20237:00 amRNSHolding(s) in Company
16th May 20231:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.